Dr Poobalan Naidoo has a passion for the medicine and clinical pharmacology. He has trained as both a pharmacist and medical doctor and has worked in the academic, pharmaceutical and clinical sectors. Dr Naidoo joined the Department of Pharmacology at the University of KwaZulu-Natal as a full time Associate lecturer in 2003 and his duties included teaching clinical pharmacology to nurses, dental therapists, physiotherapists and occupational therapists. He was also involved both in the conception and conduct of pharmacology research at undergraduate and postgraduate levels. While at university as an academic, he presented at conferences, peer reviewed for pharmacology journals and supervised honours research projects. In addition, he has evaluated clinical trials for the University Biomedical Research Ethics Committee. For his Masters thesis, he embarked on a full dissertation entitled, “Effect of Gliclazide Dose Escalation on Post-prandial hyperglycaemia in poorly controlled type 2 Diabetic Patients”. Dr Naidoo has also worked for multinational Pharmaceutical companies (Boehringer-Ingelheim, AstraZeneca, Sanofi-Aventis) as Medical Manager/Medical Advisor. He has also worked collaboratively with Novartis (Basel, Switzerland), and MSD (SA) to design Phase IV clinical trials. Therapeutic areas included type 2 diabetes mellitus, idiopathic pulmonary fibrosis, chronic obstructive lung disease, asthma, dyslipidaemia, hypertension, anti-platelets, anticoagulants, biologics, analgesia, gastrointestinal, antibiotics, visco-supplementation, hypnotics, anxiolytics, Parkinsons disease and Restless Legs Syndrome. Dr Naidoo has peer reviewed manuscripts for various journals including the highly ranked Canadian Medical Association Journal.
Dr Naidoo's research outputs include in vitro, animal, and human studies (phase I and Phase IV).